Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-806

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-806 Category Tag

Product Details

Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Dulaglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-12) Peptide-Human Igg4 Fc Fusion Protein targeting GLP-1/GLP-1-R/GLP-1R

INN Name

dulaglutide

Target

GLP1R

Format

Peptide Protein fusion

Derivation

Human

Species Reactivity

Human

CH1 Isotype

Fusion – [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 – IGHG4 Fc (Fragment constant)

VD LC

Fusion – [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 – IGHG4 Fc (Fragment constant)

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Eli?Lilly (Indianapolis IN USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

GLP1R

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide